Position history for Avoro Capital Advisors LLC's holdings in TAYSHA GENE THERAPIES INC
Avoro Capital Advisors LLC holds 21.7M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $119.4M as of 2025-Q4. TSHA represents 1.2% of Avoro Capital Advisors LLC's portfolio.
Current Value
$119.4M
Current Shares
21.7M
Total Value Change
+$77.6M
Total Shares Change
+3.1M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., MORGAN STANLEY, RTW INVESTMENTS, LP
Unchanged |
| 21.7M |
0.0% |
| $119.4M |
| 1.2% |
| $5.66 |
0 |
| 2025-Q3 | Unchanged | 21.7M | 0.0% | $71M | 0.9% | $3.16 | 0 |
| 2025-Q2 | Increased | 21.7M | +8.5% | $50.1M | 0.9% | $2.38 | 46 |
| 2025-Q1 | Unchanged | 20M | 0.0% | $27.8M | 0.4% | $1.93 | 0 |
| 2024-Q4 | Increased | 20M | +7.2% | $34.6M | 0.5% | $1.73 | 38 |
| 2024-Q3 | Unchanged | 18.7M | 0.0% | $37.5M | 0.5% | $2.07 | 0 |
| 2024-Q2 | Unchanged | 18.7M | 0.0% | $41.8M | 0.6% | $2.24 | 0 |